Home > Riviste > Minerva Anestesiologica > Fascicoli precedenti > Articles online first > Minerva Anestesiologica 2021 Oct 12

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi PROMO
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

 

Minerva Anestesiologica 2021 Oct 12

DOI: 10.23736/S0375-9393.21.15937-1

Copyright © 2021 EDIZIONI MINERVA MEDICA

lingua: Inglese

Opioid use, misuse, and abuse: a narrative review about interventions to reduce opioid consumption and related adverse events in the perioperative setting

Daniel D. KIM 1, 2, Maria F. RAMIREZ 1, 2, Juan P. CATA 1, 2

1 Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; 2 Anesthesiology and Surgical Oncology Research Group, Houston, TX, USA


PDF


Opioids remain the most potent and predictable drug available for perioperative analgesia and moderate-to-severe cancer-related pain. However, their efficacy has been questioned in other clinical settings. Moreover, opioids are associated with a wide variety of dose-dependent adverse events, limiting their use. The indiscriminate prescription of opioids has fueled the so-called “opioid epidemic” in the United States and other developed countries. Thus, there has been a significant effort to develop strategies to curtail their unnecessary prescription. Here, we summarize the history, current trends, and new directions in perioperative opioid prescription in an unbiased manner.


KEY WORDS: Opioids; Analgesia; Surgery

inizio pagina